MEDI5395: A recombinant oncolytic virus with oncolytic and immune modulatory properties

被引：2
|
作者：
Harper, James A. [1 ]
Burke, Shannon [1 ]
Leinster, Andrew [1 ]
Rath, Nicola [1 ]
Cheng, Xing [2 ]
Jin, Hong [2 ]
Wilkinson, Robert W. [1 ]
Carroll, Danielle [3 ]
机构：
[1] Medmmune Ltd, Cambridge, England
[2] Medmmune LLC, South Sanfransisco, CA USA
[3] AstraZeneca Ltd, Cambridge, England
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.SABCS18-1456
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1456
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Effects of Producer Cell Type on the Properties of Oncolytic Sindbis Virus
    Kueberuwa, G.
    Cawood, R.
    Tedcastle, A.
    Seymour, L.
    HUMAN GENE THERAPY, 2011, 22 (10) : A116 - A117
  • [42] Oncolytic efficacy of recombinant vesicular stomatitis virus and myxoma virus in experimental models of rhabdoid tumors
    Wu, Yushui
    Lun, Xueqing
    Zhou, Hongyuan
    Wang, Limei
    Sun, Beichen
    Bel, John C.
    Barrett, John W.
    McFadden, Grant
    Biegel, Jaclyn A.
    Senger, Donna L.
    Forsyth, Peter A.
    CLINICAL CANCER RESEARCH, 2008, 14 (04) : 1218 - 1227
  • [43] Development of a Regulatable Oncolytic Herpes Simplex Virus Type 1 Recombinant Virus for Tumor Therapy
    Yao, Feng
    Murakami, Nao
    Bleiziffer, Oliver
    Zhang, Pengwei
    Akhrameyeva, Natali V.
    Xu, Ximing
    Brans, Richard
    JOURNAL OF VIROLOGY, 2010, 84 (16) : 8163 - 8171
  • [44] Short synthetic double stranded RNA with dual activity - oncolytic and immune modulatory - for hepatocellular carcinoma.
    Bot, S.
    He, F.
    Newmin, W. G.
    Ghanekar, A.
    MOLECULAR BIOLOGY OF THE CELL, 2012, 23
  • [45] Oncolytic and immune effects of RAPTOR: a novel oncolytic Herpes Simplex Virus 1 expressing PTEN-L for brain tumor therapy
    Russell, Luke
    Sprague, Alexander
    Jaime-Ramirez, Alena Cristina
    Bolyard, Chelsea
    Banasavadi-Siddegowda, Yeshavanth
    Yoo, JiYoung
    Wang, Pin Yi
    Cripe, Timothy
    Kaur, Balveen
    CANCER RESEARCH, 2017, 77
  • [46] Comparison of differences in immune cells and immune microenvironment among different kinds of oncolytic virus treatments
    Wu, Xiaoke
    Fang, Shaokuan
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [47] Oncolytic vaccinia virus expressing immune checkpoint blockade antibody as cancer immunotherapeutics
    Wang, Weiyi
    Dai, Peihong
    Yang, Ning
    Shuman, Stewart
    Yan, Wei
    Merghoub, Taha
    Wolchok, Jedd D.
    Deng, Liang
    CANCER RESEARCH, 2018, 78 (13)
  • [48] Nanoparticle-induced virus immune tolerance during oncolytic therapy of gliomas
    Shin, D. H.
    Ozpolat, B.
    Gillard, A.
    Moure, M. Garcia
    Jiang, H.
    Lopez-Rivas, A.
    Parthasarathy, A.
    Fan, X.
    Alemany, R.
    Alonso, M.
    He, J.
    Ene, C.
    Al-Atrash, G.
    Lang, F.
    Gomez-Manzano, C.
    Fueyo, J.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S174 - S174
  • [49] AWAKING THE IMMUNE SYSTEM WITH AN IMMUNO-ONCOLYTIC VIRUS AS A THERAPEUTIC STRATEGY FOR DIPGS
    Laspidea, Virginia
    Puigdelloses, Montse
    Ausejo-Mauleon, Iker
    Hambardzumyan, Dolores
    Chen, Zhihong
    Martinez-Velez, Naiara
    Zalacain, Marta
    Perez de Larraya, Jaime Gallego
    Becher, Oren
    Fueyo, Juan
    Gomez-Manzano, Candelaria
    Alonso, Marta M.
    NEURO-ONCOLOGY, 2020, 22 : 471 - 471
  • [50] The oncolytic features of and innate immune responses to clinical herpes simplex virus isolates
    Lehtinen, J.
    Paavilainen, H.
    Hukkanen, V.
    HUMAN GENE THERAPY, 2015, 26 (10) : A95 - A96
12345